PIK3CA Mutations Are Associated with Pathologic Complete Response Rate to Neoadjuvant Pyrotinib and Trastuzumab Plus Chemotherapy for HER2-positive Breast Cancer.
BRITISH JOURNAL OF CANCER（2023）
关键词
Breast cancer,Predictive markers,Biomedicine,general,Cancer Research,Epidemiology,Molecular Medicine,Oncology,Drug Resistance
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要